Publications 2012

149.
Siwy J, Zoja C, Klein J, Benigni A, Mullen W, Mayer B, Mischak H, Jankowski J, Stevens R, Vlahou A, Kossida S, Perco P, Bahlmann FH.
Evaluation of the Zucker Diabetic Fatty (ZDF) Rat as a Model for Human Disease Based on Urinary Peptidomic Profiles.
PLoS One. 2012;7(12):e51334. doi: 10.1371/journal.pone.0051334. Epub 2012 Dec 7. 

View AbstractDownload     Request Reprint

 

 

148.
Zürbig P, Jahn H.
Use of proteomic methods in the analysis of human body fluids in Alzheimer research.
Electrophoresis. 2012 Dec;33(24):3617-30. doi: 10.1002/elps.201200360.

View AbstractDownload     Request Reprint

 

 

147.
Herget-Rosenthal S, Metzger J, Albalat A, Bitsika V, Mischak H.
Proteomic biomarkers for the early detection of acute kidney injury.
Prilozi. 2012 Jul;33(1):27-48.
         
View AbstractDownload     Request Reprint

 

146.
Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A; European Uremic Toxin Work Group.
Normal and pathologic concentrations of uremic toxins.
J Am Soc Nephrol. 2012 Jul;23(7):1258-70. Epub 2012 May 24.
         
View AbstractDownload     Request Reprint

 

145.
Carty DM, Schiffer E, Delles C.
Proteomics in hypertension
J Hum Hypertens. 2013 Apr;27(4):211-6. doi: 10.1038/jhh.2012.30. Epub 2012 Aug 9
 
         
View AbstractDownload     Request Reprint

144.
Zürbig P, Jerums G, Hovind P, MacIsaac R, Mischak H, Nielsen SE, Panagiotopoulos S, Persson F, Rossing P.
 Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy.
Diabetes. 2012 Dec;61(12):3304-13. doi: 10.2337/db12-0348. Epub 2012 Aug 7.
         
View AbstractDownload     Request Reprint

 

143.
Molin L, Seraglia R, Lapolla A, Ragazzi E, Gonzalez J, Vlahou A, Schanstra JP, Albalat A, Dakna M, Siwy J, Jankowski J, Bitsika V, Mischak H, Zürbig P, Traldi P.
A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases.
J Proteomics. 2012 Oct 22;75(18):5888-97. doi: 10.1016/j.jprot.2012.07.024. Epub 2012 Jul 26.
         
View AbstractDownload     Request Reprint

 

142.
 Mischak H
How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MS.
Proteomics Clin Appl. 2012 Oct;6(9-10):437-42. doi: 10.1002/prca.201200027. Epub 2012 Sep 24. 
         
View AbstractDownload     Request Reprint

 

 

141.
 Kuznetsova T, Mischak H, Mullen W, Staessen JA
Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction.
Eur Heart J. 2012 Sep;33(18):2342-50. Epub 2012 Jul 11.
         
View AbstractDownload     Request Reprint

 

140.
Dawson J, Walters M, Delles C, Mischak H, Mullen W.
Urinary proteomics to support diagnosis of stroke.
PLoS One. 2012;7(5):e35879. Epub 2012 May 16.
         
View AbstractDownload     Request Reprint

 

139.
Mischak H, Ioannidis JP, Argiles A, Attwood TK, Bongcam-Rudloff E, Broenstrup M, Charonis A, Chrousos GP, Delles C, Dominiczak A, Dylag T, Ehrich J, Egido J, Findeisen P, Jankowski J, Johnson RW, Julien BA, Lankisch T, Leung HY, Maahs D, Magni F, Manns MP, Manolis E, Mayer G, Navis G, Novak J, Ortiz A, Persson F, Peter K, Riese HH, Rossing P, Sattar N, Spasovski G, Thongboonkerd V, Vanholder R, Schanstra JP, Vlahou A.
Implementation of proteomic biomarkers: making it work.
Eur J Clin Invest. 2012 Sep;42(9):1027-1036. doi: 10.1111/j.1365-2362.2012.02674.x. Epub 2012 Apr 21.   
     
View AbstractDownload     Request Reprint

 

138.
Mullen W, Albalat A, Gonzalez J, Zerefos P, Siwy J, Franke J, Mischak H.
Performance of different separation methods interfaced in the same MS-reflection TOF detector: A comparison of performance between CE versus HPLC for biomarker analysis.
Electrophoresis. 2012 Feb;33(4):567-74. doi: 10.1002/elps.201100415.
         
View AbstractDownload     Request Reprint

 

137.
Rouse R, Siwy J, Mullen W, Mischak H, Metzger J, Hanig J
Proteomic Candidate Biomarkers of Drug-Induced Nephrotoxicity in the Rat
PLoS ONE. 2012;7(4): e34606
         
View AbstractDownload     Request Reprint

 

136.
von zur Muhlen C, Schiffer E, Sackmann C, Zürbig P, Neudorfer I, Zirlik A, Htun N, Iphöfer A, Jänsch L, Mischak H, Bode C, Chen YC, Peter K
Urine proteome analysis reflects atherosclerotic disease in an ApoE-/- mouse model and allows the discovery of new biomarkers in mouse and human atherosclerosis
 Mol Cell Proteomics. 2012 Jul;11(7):M111.013847. Epub 2012 Feb 27.

         
View AbstractDownload     Request Reprint

 

135.
Drube J, Schiffer E, Lau E, Petersen C, Kirschstein M, Kemper M, Lichtinghagen R, Ure B, Mischak H, Pape L, Ehrich JH
Urinary Proteome Analysis to Exclude Severe Vesicoureteral Reflux
Pediatrics. 2012 Feb;129(2):e356-63. Epub 2012 Jan 23.
         
View Abstract Download     Request Reprint

 

 

134.
Bandin F, Siwy J, Breuil B, Mischak H, Bascands JL, Decramer S, Schanstra JP
Urinary Proteome Analysis at 5-Year Followup of Patients With Nonoperated Ureteropelvic Junction Obstruction Suggests Ongoing Kidney Remodeling.
J Urol. 2012 Mar;187(3):1006-11. Epub 2012 Jan 20.
        
View Abstract Download     Request Reprint

 
 

133.
Schiffer E, Bick C, Grizelj B, Pietzker S, Schöfer W
Urinary proteome analysis for prostate cancer diagnosis: Cost-effective application in routine clinical practice in Germany
Int J Urol. 2012 Feb;19(2):118-25. doi: 10.1111/j.1442-2042.2011.02901.x. Epub 2011 Nov 22
        
View Abstract Download     Request Reprint